Dicerna Pharmaceuticals
Founded2007
Team size51-200
HQLexington, United States
IndustriesPharmaceutical Manufacturing
About Dicerna Pharmaceuticals
Dicerna, a wholly owned subsidiary of Novo Nordisk, is focused on driving innovation in RNAi (ribonucleic acid interference) to selectively target and silence genes that cause or contribute to disease.
Company at a glance
Location
Lexington, United States
Websitenovonordisk-us.com
LinkedInLinkedIn